Tinidazole

Specifications

19387-91-8CAS Number

243-014-4EC Number

1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazoleIUPAC Name

C8H13N3O4SChemical Formula

247.27 g/molMolecular Weight

tinidazole; 19387-91-8; Fasigyn; Trimonase; Fasigin; Tricolam; 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazole; Simplotan; Tinidazol; Sorquetan; Haisigyn; Tinidazolum; Pletil; 1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole; CP 12574; timidazole; 1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazole; 1H-Imidazole, 1-[2-(ethylsulfonyl)ethyl]-2-methyl-5-nitro-; CP-12574; 1-[2-(ethanesulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazole; DTXSID4023676; CP-12,574; Symplotan; 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitroimidazole; NSC-758189; 1H-Imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro-; CHEBI:63627; 033KF7V46H; DTXCID003676; 1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitroimidazole; Imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro-; Fasygin; Fasigyne; tinidazolo; 1-(2-(ethanesulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazole; Tindazole; CP12574; CP12,574; RefChem:56131; CP 12,574; J01XD02; P01AB02; 243-014-4; Tindamax; Bioshik; MFCD00057217; MLS000069717; 1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole; 148159-84-6; NCGC00016741-01; SMR000058194; CAS-19387-91-8; 1-(ethylsulfonyl)-2-(2-methyl-5-nitroimidazolyl)ethane; Glongyn; Amtiba; Tinidazol [INN-Spanish]; Tinidazolum [INN-Latin]; CCRIS 7621; HSDB 7362; SR-01000000210; EINECS 243-014-4; BRN 0618182; Ethyl (2-(2-methyl-5-nitro-1-imidazolyl)ethyl)sulfone; UNII-033KF7V46H; Simplotan;; Fasigyne;; Tricolam;; Glongyn;; Fasigyntrade mark; Tinidazole CRS; Tindamaxtrade mark; Simplotantrade mark; Haisigyn (TN); Tindamax (TN); Prestwick_136; Tinidazole [USAN:USP:INN:BAN:JAN]; Tinidazole (Standard); Spectrum_001266; Opera_ID_779; SpecPlus_000708; TINIDAZOLE [MI]; TINIDAZOLE [INN]; TINIDAZOLE [JAN]; Prestwick0_000766; Prestwick1_000766; Prestwick2_000766; Prestwick3_000766; Spectrum2_000648; Spectrum3_001512; Spectrum4_000230; Spectrum5_001715; TINIDAZOLE [HSDB]; TINIDAZOLE [USAN]; TINIDAZOLE [VANDF]; TINIDAZOLE [MART.]; CHEMBL1220; TINIDAZOLE [USP-RS]; TINIDAZOLE [WHO-DD]; Oprea1_342844; SCHEMBL21141; BSPBio_000812; BSPBio_003183; KBioGR_000899; KBioSS_001746; 5-23-05-00067 (Beilstein Handbook Reference); MLS001146883; MLS001424192; DivK1c_006804; SPECTRUM1502127; SPBio_000655; SPBio_002751; BPBio1_000894; orb1225797; orb1310193; Tinidazole (JP18/USP/INN); TINIDAZOLE [ORANGE BOOK]; GTPL12341; HY-B0177R; KBio1_001748; KBio2_001746; KBio2_004314; KBio2_006882; KBio3_002683; MSK5579; TINIDAZOLE [EP MONOGRAPH]; GLXC-08144; HMS1570I14; HMS1921L06; HMS2052C09; HMS2090B14; HMS2092D14; HMS2097I14; HMS2231E23; HMS3374P07; HMS3394C09; HMS3652A08; HMS3714I14; HMS5082M06; Pharmakon1600-01502127; TINIDAZOLE [USP MONOGRAPH]; HY-B0177; Tox21 110586; Tox21_110586; BBL010767; BDBM50248360; CCG-39907; EBC-08203; NSC758189; s4068; STK801761; AKOS000747070; MSK5579-1000M; Tox21_110586_1; AC-1618; CS-2055; DB00911; FT28285; KS-5180; NC00346; NSC 758189; Tinidazole 100 |Ig/mL in Acetonitrile; NCGC00016741-02; NCGC00016741-03; NCGC00016741-04; NCGC00016741-05; NCGC00016741-06; NCGC00016741-07; NCGC00016741-09; NCGC00022212-03; NCGC00022212-04; NCGC00022212-05; ST024770; Tinidazole 100 microg/mL in Acetonitrile; SBI-0052674.P002; AB00053176; NS00010248; SW196447-4; T0893; Tinidazole Solution in Methanol, 1000ug/mL; VU0239922-6; D01426; EN300-119371; Tinidazole, VETRANAL(TM), analytical standard; AB00053176-16; AB00053176_17; AB00053176_18; F241297; Q1321320; SR-01000000210-3; SR-01000000210-5; SR-01000000210-6; 1-[2-Ethylsulfonyl)ethyl]-2-methyl-5-nitroimidazole; BRD-K89125793-001-05-4; BRD-K89125793-001-25-2; BRD-K89125793-001-26-0; BRD-K89125793-001-27-8; Z56763819; 1-(2'-(ethylsulfonyl)-Ethyl]-2-Methyl-5-Nitroimidazole; Tinidazole, European Pharmacopoeia (EP) Reference Standard; Tinidazole, United States Pharmacopeia (USP) Reference Standard; IMIDAZOLE, 1-(2-(ETHYLSULFONYL)ETHYL)-2-METHYL-4-NITRO-Synonyms